FTLFDA Class 2 · 21 CFR 878.3300 · implantable

Mesh, Surgical, Polymeric

Device family · General, Plastic Surgery

Automated profile from regulatory + adverse-event registries · AI-reviewed · expert clinical sign-off in progress — not yet independently verified.
FDA clearances
340
Manufacturers
39
Flagged signals
20
Adverse-event reports
158,901

Code matrix

FDA product codeFTL
Device classClass 2
Regulation21 CFR 878.3300
GMDN— (crosswalk pending)
ImplantableYes
Life-sustainingNo

Adverse-event signals

Public · always free

MAUDE disproportionality (PRR), flagged where PRR ≥ 2, χ² ≥ 4, count ≥ 3.

Event typeYearReportsPRRχ²
201642487.17,590
Other201315475.26,638
Other2016311.619
Other2015911.173
Other201078.439
Other2017116.748
Other2016106.138
Other201056.016
Other201335.06
Other201144.89
Other201574.314
Injury201242.64
Injury201752.66
Injury200462.67
Injury2022442.459
Injury201482.38
Injury20133,5802.34,326
Injury2012142.314
Injury2013142.212
Injury20135982.1559

Device-level recall linkage pending an FDA-recalls product-code re-ingest. Class 2 family · 158,901 total adverse-event reports.

Manufacturer landscape

ManufacturerClearancesLatestConcern
W. L. Gore & Associates, Inc.362017
SOFRADIM PRODUCTION352025
C.R. Bard, Inc.252020
Ethicon, Inc.242020
Atrium Medical Corp.112012
Davol Inc., Sub. C. R. Bard, Inc.82010
Genzyme Corp.62003
United States Surgical, A Division of Tyco Healthc52001
Deep Blue Medical Advances, Inc.42023
ASPIDE MEDICAL42012
Medtronic, Inc.42020
Davol, Inc.42025
Atrium Medical Corporation32015
Caldera Medical, Inc.32010
TORNIER, INC.32012
AMERICAN MEDICAL SYSTEMS, INC.32009
MAST Biosurgery USA, Inc.32007
AESCULAP, INC.22006
TEI Biosciences, Inc.22005
Meadox Medicals, Div. Boston Scientific Corp.21994
Cook Biotech, Inc.22012
GENZYME CORPORATION22007
Nuvasive, Inc.22009
Smith & Nephew, Inc.22011
SYNTHASOME, INC.22014

Concern score lights up where a maker maps to a scored entity (depth fast-follow).

Recent FDA clearances

Parietene™ Flat Sheet Mesh · Medtronic - Sofradim Production510(k) · 2025-10-24
Onflex™ Mesh · Davol Inc., Subsidiary of C. R. Bard, Inc.510(k) · 2025-07-24
Bard® Mesh; Bard® Mesh Pre-Shaped · Davol, Inc.510(k) · 2025-06-12
Parietene™ Macroporous Mesh (PPM5050 ) · Sofradim Production510(k) · 2025-04-23
Bard Soft Mesh; Bard Soft Mesh Pre-Shaped · Davol, Inc.510(k) · 2025-04-09
ProGrip™ Self-Gripping Polypropylene Mesh · Sofradim Production510(k) · 2025-01-17
3DMax Light Mesh · Davol Inc., Subsidiary of C. R. Bard, Inc.510(k) · 2024-06-14
Progrip™ Self-Gripping Polypropylene Mesh · Sofradim Production510(k) · 2024-01-18
Bard 3DMax Mesh · Davol Inc., Subsidiary of C. R. Bard, Inc.510(k) · 2023-11-01
T-Line® Hernia Mesh · Deep Blue Medical Advances, Inc.510(k) · 2023-10-18
Pitch PaSoft Tissue Reinforcement Device · Xiros, Ltd.510(k) · 2023-05-31
T-Line Hernia Mesh · Deep Blue Medical Advances, Inc.510(k) · 2023-02-23
Parietene Macroporous Mesh · Sofradim Production510(k) · 2022-12-02
T-Line Hernia Mesh · Deep Blue Medical Advances, Inc.510(k) · 2022-11-28
ProGrip Self-Gripping Polypropylene Mesh · Covidien510(k) · 2022-09-22
Poly-Tape/Infinity-Lock Soft Tissue Reinforcement Device · Xiros, Ltd.510(k) · 2022-08-26
Symbotex Composite Mesh, ProGrip Self-Gripping Polyester Mesh, Parietex Hydrophilic 2D 3D Anatomical Mesh, Versatex Monofilament Mesh · Sofradim Production510(k) · 2022-06-22
ARISTE AB Mesh · Ariste Medical, LLC510(k) · 2022-03-18
Pitch-Patchs · Xiros, Ltd.510(k) · 2021-08-13
SurgiWrap FROST · Mast Biosurgery510(k) · 2021-01-07
VICRYL Mesh · ETHICON, Inc.510(k) · 2020-08-06
3DMax MID Anatomical Mesh · C.R. Bard, Inc.510(k) · 2020-07-17
TYRX Neuro Absorbable Antibacterial Envelope (Medium), TYRX Neuro Absorbable Antibacterial Envelope (Large) · Medtronic, Inc.510(k) · 2020-04-08
T-Line Hernia Mesh · Deep Blue Medical Advances, Inc.510(k) · 2020-03-30
TYRX Absorbable Antibacterial Envelope (medium), TYRX Absorbable Antibacterial Envelope (large) · Medtronic, Inc.510(k) · 2020-03-27

Sources: FDA 510(k)/PMA · openFDA MAUDE · FDA device classification · MedevIQ manufacturer-canonical. Registry data, AI-reviewed; expert clinical sign-off in progress.

Early access

MedevIQ is in private preview.

We're onboarding hospitals, manufacturers, regulators and research teams in waves. Tell us how you'd use MedevIQ and we'll get back within a working week.

We'll reply within a working week.

Access by invitation while v1 finalizes.